AVR anteris technologies global corp.

Admedus Immunotherapy Deal

  1. 3,092 Posts.
    lightbulb Created with Sketch. 69
    Thank you to the Good Doctor who originally posted this.

    "Mr Paterson says he will “know either way” by the end of March if the company (ASX:AHZ) has a partner that will take the lead financially for the drug development business."

    https://**promotion blocked**/health/med...r-profit-after-near-death-experience-says-ceo

    Very very exciting. The funds this could attract will be put to brilliant use accelerating the sale of the company's ADAPT products across the world and also in the development of our 3D vascular patch (which I believe will be used in surgeries for the femoral artery...)
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$8.22
Change
0.120(1.48%)
Mkt cap ! $118.1M
Open High Low Value Volume
$8.00 $8.39 $8.00 $95.96K 11.53K

Buyers (Bids)

No. Vol. Price($)
3 133 $8.35
 

Sellers (Offers)

Price($) Vol. No.
$8.39 133 1
View Market Depth
Last trade - 13.39pm 16/09/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.